Olin Q4 Adjusted EBITDA misses estimates

Reuters
01/30
Olin Q4 Adjusted EBITDA misses estimates

Overview

  • Chemical and ammunition maker's Q4 revenue beat analyst expectations

  • Adjusted EBITDA for Q4 missed analyst expectations

  • Company reported Q4 net loss of $85.7 mln due to market headwinds and disruptions

Outlook

  • Olin expects Q1 2026 adjusted EBITDA to be lower than Q4 2025

  • Winchester segment Q1 2026 results expected to modestly increase from Q4 2025

  • Epoxy business anticipated to return to profitability in 2026

Result Drivers

  • MARKET HEADWINDS - Olin faced continued market headwinds, including customer destocking and operational challenges, impacting its Chlor Alkali Products and Vinyls segment

  • EPOXY SALES INCREASE - Higher volumes and a favorable product mix led to increased sales in the Epoxy segment

  • RAW MATERIAL COSTS - Rising raw material costs impacted Winchester's earnings

Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

Q4 Revenue

Beat

$1.67 bln

$1.55 bln (14 Analysts)

Q4 Net Income

-$85.50 mln

Q4 Adjusted EBITDA

Miss

$67.70 mln

$74.28 mln (15 Analysts)

Q4 EBIT

-$81.50 mln

Q4 Pretax Profit

-$122.90 mln

Analyst Coverage

  • The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 3 "strong buy" or "buy", 13 "hold" and 1 "sell" or "strong sell"

  • The average consensus recommendation for the commodity chemicals peer group is "buy."

  • Wall Street's median 12-month price target for Olin Corp is $23.00, about 1.1% above its January 28 closing price of $22.74

  • The stock recently traded at 55 times the next 12-month earnings vs. a P/E of 26 three months ago

Press Release: ID:nPn2Zprqwa

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

应版权方要求,你需要登录查看该内容

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10